Volume 16, Issue 1 (January 2018)                   IJRM 2018, 16(1): 1-8 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saghafi N, Pourali L, Ghavami Ghanbarabadi V, Mirzamarjani F, Mirteimouri M. Serum heat shock protein 70 in preeclampsia and normal pregnancy: A systematic review and meta-analysis. IJRM 2018; 16 (1) :1-8
URL: http://ijrm.ir/article-1-943-en.html
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , pouralil@mums.ac.ir
3- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
4- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:   (3109 Views)
Background: Preeclampsia, a severe complication of human pregnancy is one of the main causes of maternal, fetal, and neonatal morbidity and mortality with unclear pathogenesis. Heat shock protein 70 (HSP70) is one of the factors that can mediate cytoprotective, antiapoptotic, and immune regulatory effects.
Objective: This meta-analysis was performed with aim to evaluate HSP70 in preeclampsia and normal pregnancy.
Materials and Methods: The original publications reporting the serum HSP70 levels in preeclampsia and normal pregnancies published before November 2015 were identified by searching PubMed Central, Scopus, and ISI Web of Knowledge databases by two researchers, separately. The keywords were” preeclampsia” and “HSP70” or “Heat shock protein 70” Statistical analyses were performed using STATA software (version 11).
Results: Out of 127 studies, seven eligible case-control studies were identified which consists of 350 preeclampsia and 429 normal pregnancies. Our pooled analysis of data from 7 studies which met the inclusion criteria, provides evidence that there is a significant association between HSP70 and preeclampsia. Cochran's test results showed the heterogeneity of the studies (p<0.001) and the I2 index was 91%. The standardized mean differences (SMD) based on a random effect model with trim and fill method was 0.92 (95% CI: 0.33-1.51); also there was a significant association between HSP70 and preeclampsia (Z=3.07, p=0.002).
Conclusion: The results showed that serum HSP70 concentration was significantly higher in preeclamptic patients than the control group. Therefore HSP70 may be identified as a diagnostic factor.
Full-Text [PDF 585 kb]   (898 Downloads) |   |   Full-Text (HTML)  (472 Views)  
Type of Study: Review Article |

References
1. Saleem S, McClure EM, Goudar SS, Patel A, Esamai F, Garces A, et al. A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries. Bull World Health Organ 2014; 92: 605-612. [DOI:10.2471/BLT.13.127464]
2. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the united states, 1980-2010: age-period-cohort analysis. BMJ 2013; 347: f6564. [DOI:10.1136/bmj.f6564]
3. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014; 4: 97-104. [DOI:10.1016/j.preghy.2014.02.001]
4. English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control 2015; 8: 7-12.
5. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28: 192-209. [DOI:10.1016/j.mam.2007.02.006]
6. Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy 2014; 2014: 910751. [DOI:10.1155/2014/910751]
7. Li Z, Srivastava P. Heat-shock proteins. Curr Protoc Immunol 2004 Feb; Appendix 1: Appendix 1T.
8. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 2003; 362: 469-476. [DOI:10.1016/S0140-6736(03)14075-5]
9. Rodriguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol 2014; 10: 56-62. [DOI:10.1038/nrneph.2013.248]
10. Molvarec A, Prohaszka Z, Nagy B, Szalay J, Fust G, Karadi I, et al. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hyperten 2006; 20: 780-786. [DOI:10.1038/sj.jhh.1002060]
11. Jirecek S, Hohlagschwandtner M, Tempfer C, Knofler M, Husslein P, Zeisler H. Serum levels of heat shock protein 70 in patients with preeclampsia: a pilot-study. Wien klin Wochenschr 2002; 114: 730-732.
12. Molvarec A, Derzsy Z, Kocsis J, Boze T, Nagy B, Balogh K, et al. Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress Chaperones 2009; 14: 491-498. [DOI:10.1007/s12192-009-0102-4]
13. Zhu J, Li M, Li L. Expression and significance of heat shock protein 70 in maternal serum, umbilical cord blood and placenta of patients with hypertensive disorders complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi 2014; 49: 676-680.
14. Molvarec A, Szarka A, Walentin S, Beko G, Karadi I, Prohaszka Z, et al. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta 2011; 412: 1957-1962. [DOI:10.1016/j.cca.2011.06.042]
15. Molvarec A, Rigó J Jr, Lázár L, Balogh K, Makó V, Cervenak L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009; 14: 151-159. [DOI:10.1007/s12192-008-0067-8]
16. Molvarec A, Prohaszka Z, Nagy B, Szalay J, Fust G, Karadi I, et al. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hypertens 2006; 20: 780-786. [DOI:10.1038/sj.jhh.1002060]
17. Molvarec A, Prohaszka Z, Nagy B, Kalabay L, Szalay J, Fust G, et al. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 2007; 73: 172-179. [DOI:10.1016/j.jri.2006.07.002]
18. Livingston JC, Ahokas R, Haddad B, Sibai BM, Awaads R. Heat shock protein 70 is not increased in women with severe preeclampsia. Hypertens Pregnancy 2002; 21: 123-126. [DOI:10.1081/PRG-120004767]
19. Fukushima A, Kawahara H, Isurugi C, Syoji T, Oyama R, Sugiyama T, et al. Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia. J Obstet Gynaecol Res 2005; 31: 72-77. [DOI:10.1111/j.1447-0756.2005.00244.x]
20. Peracoli JC, Bannwart-Castro CF, Romao M, Weel IC, Ribeiro VR, Borges VT, et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia. J Reprod Immunol 2013; 100: 129-134. [DOI:10.1016/j.jri.2013.08.003]
21. Fukushima A, Kawahara H, Isurugi C, Syoji T, Oyama R, Sugiyama T, et al. Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia. J Obstet Gynaecol Res 2005; 31: 72-77. [DOI:10.1111/j.1447-0756.2005.00244.x]
22. Akbarzadeh-Jahromi M, Daneshyar Z, Sari Aslani F, Asadi N, Zare HR. Circulating levels of heat shock protein 70 in women with preeclampsia and healthy controls. Shiraz E-Med J 2015; 16: e27750. [DOI:10.17795/semj27750]
23. Kelley GA, Kelley KS. Statistical models for meta-analysis: A brief tutorial. World J Methodol 2012; 2: 27-32. [DOI:10.5662/wjm.v2.i4.27]
24. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias inmeta-analysis. Biometrics 2000; 56: 455-463. [DOI:10.1111/j.0006-341X.2000.00455.x]
25. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13. [DOI:10.1186/1471-2288-5-13]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb